S. Sato

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S Sato, S. Sato, Shinichi Sato, Shinichi Sato]
Publication record
629 papers · 17,934 citations · H-index 70

PAPERS

Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis
20234 citationsauthor #4
Serum cold-inducible RNA-binding protein levels as a potential biomarker for systemic sclerosis-associated interstitial lung disease
20239 citationsauthor #9
1073 Fasudil ameliorates fibrosis and immune abnormalities in animal models of systemic sclerosis
20230 citationsauthor #3
Bitter taste receptor T2R38 is expressed on skin-infiltrating lymphocytes and regulates lymphocyte migration
202216 citationsauthor #6
Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome
20222 citationsauthor #13
Poor prognostic factors of Sézary syndrome: A retrospective single‐center study from Japan
20220 citationsauthor #12
Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases
202216 citationsauthor #5
Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration
20223 citationsauthor #11
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
202215 citationsauthor #18
Interleukin-26–DNA complexes promote inflammation and dermal-epidermal separation in a modified human cryosection model of bullous pemphigoid
20225 citationsauthor #7
New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics
202237 citationsauthor #3
Involvement of B cells in the development of systemic sclerosis
202223 citationsauthor #5
Decreased keratinocyte Proline‐Rich protein expression in cutaneous T‐cell lymphoma
20220 citationsauthor #11
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial.
202244 citationsauthor #14
Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing γδ T cells in secondary lymph nodes.
202115 citationsauthor #6
Serum levels of tissue factor pathway inhibitor: Potential association with Raynaud’s phenomenon and telangiectasia in patients with systemic sclerosis
20215 citationsauthor #10
Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis
202114 citationsauthor #14
Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome
20219 citationsauthor #6
A potential contribution of decreased serum galectin‐10 levels to systemic inflammation and pulmonary vascular involvement in systemic sclerosis
20212 citationsauthor #10
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
202118 citationsauthor #9
The contribution of LIGHT to the development of systemic sclerosis by modulating IL-6 and Th1 chemokine expression in dermal fibroblasts.
20213 citationsauthor #11
Cutaneous Sarcoidosis as a Predictor of Cardiac Sarcoidosis
20212 citationsauthor #13
Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
20216 citationsauthor #8
Fibrosarcomatous dermatofibrosarcoma protuberans in a seven-year-old boy
20210 citationsauthor #11
Development of a prediction model of treatment response in patients with cutaneous arteritis: Insights from a cohort of 33 patients
20216 citationsauthor #9
Serum vasohibin‐1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis
20218 citationsauthor #11
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial.
2021172 citationsauthor #15
Linear childhood discoid lupus erythematosus along a Blaschko's line of the arm
20211 citationsauthor #3
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis
202163 citationsauthor #15
Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model
202137 citationsauthor #11
Rapidly progressive interstitial lung disease associated with dermatomyositis—Longitudinal course of anti‐MDA5 antibody titer in two cases
20210 citationsauthor #6
Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease
20218 citationsauthor #8
Dermatomyositis‐like eruptions and fasciitis with novel compound heterozygous MEFV mutations: Newly recognized features of a variant of familial Mediterranean fever
20210 citationsauthor #9
Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis‐associated interstitial lung disease
20216 citationsauthor #8
Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination
20219 citationsauthor #10
Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis
20219 citationsauthor #10
Lymphatic dysfunction exacerbates cutaneous tumorigenesis and psoriasis-like skin inflammation through accumulation of inflammatory cytokines.
20216 citationsauthor #8
Author response: Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model
20211 citationsauthor #11
Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis
20216 citationsauthor #8
A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab
20218 citationsauthor #7
B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis
202137 citationsauthor #11
Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid‐binding protein, whose expression decreases with loss of epidermotropism
20217 citationsauthor #8
Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis
20216 citationsauthor #6
Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
202113 citationsauthor #11
Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
20213 citationsauthor #10
Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia
20212 citationsauthor #12
The expert-level distinction of systemic sclerosis from hand photographs using the deep convolutional neural network.
202110 citationsauthor #14
Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study
20216 citationsauthor #8
A Case of Cytomegalovirus-Induced Oral Ulcer in an Older Adult Patient with Nephrotic Syndrome due to Membranous Nephropathy
20202 citationsauthor #1
Overlapping systemic sclerosis and sarcoidosis with mutually exclusive disease activities: a case report and analysis of previous studies
20201 citationsauthor #2
Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan
20205 citationsauthor #10
CX3CR1 Deficiency Attenuates DNFB-Induced Contact Hypersensitivity through Skewed Polarization towards M2 Phenotype in Macrophages
20209 citationsauthor #7
A Case of Systemic Sclerosis Complicated With Portal Hypertension.
20202 citationsauthor #6
TLR2 Deﬁciency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inﬂammation through Decrease in Regulatory T Cells and Impaired IL-10 Production
20203 citationsauthor #8
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma‐like Vasculopathy in KLF5+/−;Fli‐1+/− Mice
202018 citationsauthor #14
Decreased serum cathepsin S levels in patients with systemic sclerosis‐associated interstitial lung disease
20207 citationsauthor #11
Subacute thyroiditis in psoriasis patients treated with biologics targeting tumor necrosis factor‐α and interleukin‐17A, a report of two cases
20202 citationsauthor #3
Case of systemic sclerosis with multiple primary malignancies in whom anti‐RNA polymerase III antibody was detected by immunoprecipitation
20201 citationsauthor #6
A case of folliculotropic mycosis fungoides successfully treated with topical steroid treatment.
20200 citationsauthor #4
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma
202011 citationsauthor #10
Characteristics of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Anticentriole Autoantibodies.
20204 citationsauthor #9
Whole‐exome sequencing and host cell reactivation assay lead to a diagnosis of xeroderma pigmentosum group D with mild ultraviolet radiation sensitivity
20201 citationsauthor #9
Interleukin (IL)‐17F and IL‐17E are related to fibrosis and vasculopathy in systemic sclerosis
202015 citationsauthor #9
Assessment of the risk of malnutrition due to aspiration pneumonia and oral feeding difficulty.
20202 citationsauthor #1
Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study
20205 citationsauthor #14
Serum delta‐like 4 levels: A possible association with interstitial lung disease in systemic sclerosis
20200 citationsauthor #8
Case of aquagenic urticaria: Case report and the results of histopathological examination
20204 citationsauthor #3
Association of serum CXCL12 levels with arthropathy in patients with systemic sclerosis
20206 citationsauthor #10
Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis
20207 citationsauthor #12
Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis
202010 citationsauthor #10
TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production
202023 citationsauthor #8
Single-cell analysis of autoreactive B cells in patients with systemic sclerosis revealed that responses to therapy are determined by effector and regulatory B cell balance
20201 citationsauthor #4
Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study
20202 citationsauthor #11
Inhibitory role of interleukin‐10 in the cutaneous reverse Arthus reaction
20202 citationsauthor #7
Generalized Argyria Successfully Treated with Q-switched Alexandrite Laser: A Case Report
20202 citationsauthor #6
Unusual type of scleromyxedema with multiple subcutaneous nodules, IgM-λ paraproteinemia, and scleroderma-like microangiopathy
20201 citationsauthor #7
COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis.
20204 citationsauthor #6
Primary cutaneous γδ T‐cell lymphoma with unusual immunophenotype: A case report and review of published work
20204 citationsauthor #8
A Case of Multiple Phleboliths on the Medial Side of the Right Mandible
20208 citationsauthor #1
Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice
20209 citationsauthor #4
Serum heat shock protein 27 levels in patients with systemic sclerosis: a possible biomarker of skin sclerosis
20202 citationsauthor #12
Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
20200 citationsauthor #2
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.
20208 citationsauthor #10
Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study
20207 citationsauthor #4
Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
202011 citationsauthor #21
Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody
20201 citationsauthor #2
Rapid decrease of serum surfactant protein‐D levels predicts the reactivity of rituximab therapy in systemic sclerosis‐associated interstitial lung disease
20205 citationsauthor #6
Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis
202045 citationsauthor #7
Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides
20201 citationsauthor #9
HMGB1-mediated chromatin remodeling attenuates Il24 gene expression for the protection from allergic contact dermatitis
202019 citationsauthor #13
Erratum: Characteristics of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Anticentriole Autoantibodies.
20200 citationsauthor #9
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease
201953 citationsauthor #8
Cutaneous phaeohyphomycosis caused by Alternaria alternata in an immunosuppressed patient
20194 citationsauthor #9
A case of erythema multiforme major presenting with varicella‐like manifestations
20191 citationsauthor #7
Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis
20190 citationsauthor #7
Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein
201916 citationsauthor #8
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
201915 citationsauthor #11
Osteogenic melanoma of the right fifth toe
20192 citationsauthor #10
Novel topical and systemic therapies in atopic dermatitis
201929 citationsauthor #2
IL‐10–producing regulatory B cells in skin diseases
20195 citationsauthor #2

TIMELINE

1995 6 citations

1996 34 citations

1997 205 citations

1998 25 citations

2000 328 citations

2001 0 citations

2002 264 citations

2003 568 citations

2004 1,474 citations

2005 659 citations

2006 963 citations

2007 721 citations

2008 836 citations

2009 686 citations

2010 1,698 citations

2011 1,630 citations

2012 1,073 citations

2013 1,258 citations

2014 1,120 citations

2015 1,045 citations

2016 436 citations

2017 832 citations

2018 680 citations

2019 463 citations

2020 270 citations

2021 498 citations

2022 161 citations

2023 13 citations

Unknown 4 citations

S. Sato

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT